Literature DB >> 8851748

Spectral characterization of fluconazole.

T D Cyr1, B A Dawson, G A Neville, H F Shurvell.   

Abstract

Reference 1H, 19F and 13C NMR, mass, IR and Raman spectra are provided to the open literature for the first time for the potent antifungal agent fluconazole, alpha-(2,4-difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl++ +)-1H-1,2, 4-triazole-1-ethanol. The 1H, 19F and 13C NMR spectra were analyzed in detail to attribute shifts, including 19F chemical shifts and C-F and F-F coupling constants. The EI mass spectrum, although rich in fragment ions, lacked a molecular ion. FAB and MS/MS experiments were undertaken in support of the structure in order to validate the EI spectrum as a reference mass spectrum. IR and Raman spectra are compared to show the complementary nature of their features and discussed in terms of principal group vibrations. NMR and vibrational data together with assignments are summarized in tabulated form for convenience of use. All these data are consistent with the structure of fluconazole.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851748     DOI: 10.1016/0731-7085(95)01598-1

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Investigating the performance of drug delivery system of fluconazole made of nano-micro fibers coated on cotton/polyester fabric.

Authors:  Dariush Semnani; Mehran Afrashi; Farzaneh Alihosseini; Parvin Dehghan; Mehrnoosh Maherolnaghsh
Journal:  J Mater Sci Mater Med       Date:  2017-09-27       Impact factor: 3.896

2.  Solid-state characterization and impurities determination of fluconazol generic products marketed in Morocco.

Authors:  Houda Bourichi; Youness Brik; Philipe Hubert; Yahia Cherrah; Abdelaziz Bouklouze
Journal:  J Pharm Anal       Date:  2012-08-17

3.  In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates.

Authors:  Renata Cougo Moraes; Anderson Ramos Carvalho; Aline Jacobi Dalla Lana; Samuel Kaiser; Bruna Pippi; Alexandre Meneghello Fuentefria; George González Ortega
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

4.  Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential.

Authors:  Nevena Lj Stevanović; Ivana Aleksic; Jakob Kljun; Sanja Skaro Bogojevic; Aleksandar Veselinovic; Jasmina Nikodinovic-Runic; Iztok Turel; Miloš I Djuran; Biljana Đ Glišić
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-30

5.  Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.

Authors:  Tayel A Al Hujran; Mousa K Magharbeh; Almeqdad Y Habashneh; Rasha S Al-Dmour; Ashraf Aboelela; Hesham M Tawfeek
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

6.  New Approach to Antifungal Activity of Fluconazole Incorporated into the Porous 6-Anhydro-α-l-Galacto-β-d-Galactan Structures Modified with Nanohydroxyapatite for Chronic-Wound Treatments-In Vitro Evaluation.

Authors:  Justyna Rewak-Soroczynska; Paulina Sobierajska; Sara Targonska; Agata Piecuch; Lukasz Grosman; Jaroslaw Rachuna; Slawomir Wasik; Michal Arabski; Rafal Ogorek; Rafal J Wiglusz
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.